untitled design

Tag: NEJM

J&j Vaccine Protects All Trial Participants From Hospitalization And Death In COVID-19

J&j Vaccine Protects All Trial Participants From Hospitalization And Death In COVID-19

Johnson & Johnson’s single-dose vaccine fully protects against hospitalization and death with COVID-19 approximately one month after administration. This is also true for countries where mutant variants of the coronavirus are common. J&J Chief Scientist Paul Stoffels said this, commenting on the publication of primary data from phase III clinical trials in the New England […]